Confluence of factors are bringing investment into biotech sector, says StemPoint’s Michelle Ross

Michelle Ross, StemPoint Capital CIO, joins ‘Closing Bell’ to discuss Ross’ thoughts on the recent news in the biotech space, what the CIO expects to continue and much more.